Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease

Biochemical and Biophysical Research Communications - United States
doi 10.1016/j.bbrc.2016.09.036
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search